Publication: 96 weeks of pegylated-interferon- alpha-2α plus tenofovir or placebo for the treatment of hepatitis delta: The hidit-2 study
dc.contributor.author | Wedemeyer, Heiner | |
dc.contributor.author | Yurdaydin, Cihan | |
dc.contributor.author | Ernst, Stefanie | |
dc.contributor.author | Caruntu, Florin A. | |
dc.contributor.author | Curescu, Manuela G. | |
dc.contributor.author | Yalcin, Kendal | |
dc.contributor.author | Akarca, Ulus S. | |
dc.contributor.author | Zeuzem, Stefan | |
dc.contributor.author | Erhardt, Andreas | |
dc.contributor.author | Lueth, Stefan | |
dc.contributor.author | Papatheodoridis, George | |
dc.contributor.author | Keskin, Onur | |
dc.contributor.author | Port, Kerstin | |
dc.contributor.author | Celen, Mustafa K. | |
dc.contributor.author | Stift, Judith | |
dc.contributor.author | Heidrich, Benjamin | |
dc.contributor.author | Mederacke, Ingmar | |
dc.contributor.author | Hardtke, Svenja | |
dc.contributor.author | Koch, Armin | |
dc.contributor.author | Dienes, Hans P. | |
dc.contributor.author | Manns, Michael P. | |
dc.contributor.buuauthor | Gürel, Selim | |
dc.contributor.buuauthor | GÜREL, SELİM | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi | |
dc.contributor.researcherid | HLH-8209-2023 | |
dc.date.accessioned | 2024-08-16T08:36:53Z | |
dc.date.available | 2024-08-16T08:36:53Z | |
dc.date.issued | 2013-10-01 | |
dc.description | Bu çalışma, 01-05 Kasım2013 tarihleri arasında Washington [ABD]’da düzenlenen 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur. | |
dc.description.sponsorship | Amer Assoc Study Liver Dis | |
dc.identifier.endpage | 223A | |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issue | Supplement1, Special IssueSI | |
dc.identifier.startpage | 222A | |
dc.identifier.uri | https://hdl.handle.net/11452/44125 | |
dc.identifier.volume | 58 | |
dc.identifier.wos | 000330252201031 | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.ISTP | |
dc.language.iso | en | |
dc.publisher | Wiley-blackwell | |
dc.relation.journal | Hepatology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Gastroenterology & hepatology | |
dc.title | 96 weeks of pegylated-interferon- alpha-2α plus tenofovir or placebo for the treatment of hepatitis delta: The hidit-2 study | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | d7a9ea11-69fc-4122-a365-8fb2123512e6 | |
relation.isAuthorOfPublication.latestForDiscovery | d7a9ea11-69fc-4122-a365-8fb2123512e6 |